1
A Phase I Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: September 12, 2012Recruiting
5 Clinical Trials for: “Multiple Myeloma Research Consortium”, Page 1 of 1
Hide Studies Not Seeking New Volunteers
2
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: May 9, 2013Recruiting
3
A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: May 6, 2013Recruiting
4
Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma
Condition(s): Multiple Myeloma; Relapsed Multiple Myeloma; Refractory Multiple Myeloma Last Updated: May 16, 2013Active, not recruiting
5
Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: October 15, 2012Recruiting
